Tocilizumab for severe COVID-19 related illness – A community academic medical center experience

The SARS-CoV-2 virus responsible for the COVID-19 pandemic can result in severe or fatal disease in a subset of infected patients. While the pathogenesis of severe COVID-19 disease has yet to be fully elucidated, an overexuberant and harmful immune response to the SARS-CoV-2 virus may be a pivotal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Meleveedu, Kapil S, Miskovsky, John, Meharg, Joseph, Abdelrahman, Abd, Tandon, Richa, Moody, Ashley E., Dasilva, Priscilla, Masse, Gabrielle, LaPorte, Jason, Saied Calvino, Abdul, Allen, Greg, El-Bizri, Rabih, Roberts, Todd, Armenio, Vincent, Katz, Steven C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467014/
https://www.ncbi.nlm.nih.gov/pubmed/32895645
http://dx.doi.org/10.1016/j.cytox.2020.100035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467014/
https://www.ncbi.nlm.nih.gov/pubmed/32895645
http://dx.doi.org/10.1016/j.cytox.2020.100035

Ejemplares similares